vimarsana.com

Page 14 - மருத்துவ ஆராய்ச்சி ஆர்கநைஸேஶந் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Enzolytics Announces the Filing of Updated NIH Grant Applications Incorporating Newly Identified Conserved Epitopes on Both the HIV-1 and SARS-CoV-2 Viruses; Other Corporate Updates

Enzolytics Announces the Filing of Updated NIH Grant Applications Incorporating Newly Identified Conserved Epitopes on Both the HIV-1 and SARS-CoV-2 Viruses; Other Corporate Updates
tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.

Enzolytics Announces the Filing of Updated NIH Grant Applications Incorporating Newly Identified Conserved Epitopes on Both the HIV-1 and SARS-CoV-2 Viruses; Other Corporate Updates

Enzolytics Announces the Filing of Updated NIH Grant Applications Incorporating Newly Identified Conserved Epitopes on Both the HIV-1 and SARS-CoV-2 Viruses; Other Corporate Updates
saltlakecitysun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from saltlakecitysun.com Daily Mail and Mail on Sunday newspapers.

BOI opens three activities

Clinical Data Management Market to Witness Tremendous Growth,Size,Shape,New Technologies And Forecast 2027

Clinical Data Management Market to Witness Tremendous Growth,Size,Shape,New Technologies And Forecast 2027
sandiegosun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sandiegosun.com Daily Mail and Mail on Sunday newspapers.

MCRA Hires Cardiovascular Industry Leader Dr Hans-Peter Stoll to its CRO Management Team

Share this article Share this article WASHINGTON, March 11, 2021 /PRNewswire/ MCRA, LLC, a leading medical device and biologics advisory firm and clinical research organization (CRO) dedicated to integrating US and International Regulatory, Clinical Research, Reimbursement, Healthcare Compliance, and Quality Assurance, is pleased to announce the hiring of Dr. Hans-Peter Stoll, an interventional cardiologist. Dr. Stoll formerly served as Chief Medical Officer at Biosensors International where he led the clinical affairs group and provided medical strategic leadership to executive management. Additional cardiovascular device industry experience includes roles as Chief Medical Officer Cardiology at GE Healthcare and as Worldwide Vice President Clinical Research at Cordis, a Johnson & Johnson company.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.